Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Alexion Pharmacteuicals Sank 8.9% in November

TheMotleyFool

0 0

Why Alexion Pharmacteuicals Sank 8.9% in November

Shares of Alexion Pharmaceuticals (NASDAQ: ALXN), a commercial-stage biotech focused on rare diseases, fell 9% in November, according to data from S&P Global Market Intelligence. There doesn't appear to be any company-specific news that can explain the decline. Instead, it's likely that the pessimism from October simply carried over.

Image source: Getty Images.

While it was mostly a quiet month for the biotech, a few key news items were released during the period:

Source: Fool.com